Home/Companies/Biotech/Exeliom Biosciences

Exeliom Biosciences

France·Active·9yr hold

Entry

2017

Hold

9yr

Status

Active

Who owns Exeliom Biosciences?

Exeliom Biosciences is a French Biotech company, currently owned by Capital Grand Est since 2017.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY

Investor

Capital Grand Est

Cap Innov'Est 1 · 2014 · VC

Key facts

HQFrance

SectorBiotech

Websitewww.exeliombio.com

More from Cap Innov'Est 1

Other portfolio companies in the same fund.

Business Services

to Jérémy Wies, Michel Lacombe and Guillaume Philipp

Urania Therapeutics

to Turenne Groupe

to SmartBear Software

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

The Carlyle GroupChina

General AtlanticChina

Advanced Cell Diagnostics

Summit Partners

Akero Therapeutics

General Atlantic

Alloy Therapeutics

Mubadala Capital

Questions

Who owns Exeliom Biosciences?

Exeliom Biosciences is currently owned by Capital Grand Est, through Cap Innov'Est 1, since 2017.

When did Capital Grand Est acquire Exeliom Biosciences?

Capital Grand Est acquired Exeliom Biosciences in 2017.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue